Detect-ION partners with Mayo Clinic Florida to evaluate the potential of breath to detect Pseudomonas aeruginosa (PA) – a major cause of pneumonia in high-risk and immunocompromised patients.

Detect-ION expands our operations to centrally located 4,000 square-foot state-of-the-art laboratory in Tampa, FL.

Detect-ION inaugurates our first instrumentation lab at USF Connect, establishing a dedicated space for R&D to advance our sensor technology.

Detect-ION is inducted into the Tampa Bay Technology Incubator, USF’s catalyst for the creation and development of high-technology companies. Go Bulls!

Detect-ION opened our on-site Breath Research Lab facility to advance real-time breath diagnostics research. 

Detect-ION partners with Moffitt Cancer Center to develop lung cancer breath diagnostics.

Detect-ION invests in high-resolution mass spectrometry (HRMS) to facilitate breath biomarker discovery and point-of-care breath diagnostics pilots.

The Gates Foundation selects Detect-ION to conduct a breath diagnostics trial for malaria and tuberculosis in low- and middle-income countries. 

Detect-ION is selected by IARPA to lead a multi-organizational team to develop an aerosolized chemical threat detection capability for the U.S. intelligence community under the PICARD program. 

Detect-ION wins it’s first major contact: DTRA and DIU‘s EXHALE Program award to develop rapid, non-invasive breath diagnostics for pre-symptomatic infections.